291 related articles for article (PubMed ID: 36048895)
21. Economic Outcomes of First-Line Regimen Switching Among Stable Patients with HIV.
Rosenblatt L; Buikema AR; Seare J; Bengtson LGS; Johnson J; Cao F; Villasis-Keever A
J Manag Care Spec Pharm; 2017 Jul; 23(7):725-734. PubMed ID: 28650246
[TBL] [Abstract][Full Text] [Related]
22. The economic burden of HIV-associated wasting in the era of modern antiretroviral therapy.
Siddiqui J; Samuel SK; Hayward B; Wirka KA; Deering KL; Harshaw Q; Phillips A; Harbour M
J Manag Care Spec Pharm; 2022 Oct; 28(10):1180-1189. PubMed ID: 35939048
[No Abstract] [Full Text] [Related]
23. Epidemiology and Economic Burden of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma in the United States.
Jonasch E; Song Y; Freimark J; Berman R; Nguyen H; Signorovitch J; Sundaram M
Clin Genitourin Cancer; 2023 Apr; 21(2):238-247. PubMed ID: 36682891
[TBL] [Abstract][Full Text] [Related]
24. All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States.
Mostaghimi A; Gandhi K; Done N; Ray M; Gao W; Carley C; Wang T; Swallow E; Sikirica V
J Manag Care Spec Pharm; 2022 Apr; 28(4):426-434. PubMed ID: 35332790
[No Abstract] [Full Text] [Related]
25. Risk of chemotherapy-induced febrile neutropenia in intermediate-risk regimens: Clinical and economic outcomes of granulocyte colony-stimulating factor prophylaxis.
Aslam S; Li E; Bell E; Lal L; Anderson AJ; Peterson-Brandt J; Lyman G
J Manag Care Spec Pharm; 2023 Feb; 29(2):128-138. PubMed ID: 36705281
[No Abstract] [Full Text] [Related]
26. Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics.
Pilon D; Patel C; Lafeuille MH; Zhdanava M; Lin D; Côté-Sergent A; Rossi C; Lefebvre P; Joshi K
J Manag Care Spec Pharm; 2021 Jul; 27(7):904-914. PubMed ID: 34185557
[No Abstract] [Full Text] [Related]
27. It is time for a new comprehensive medication review quality measure.
Castora-Binkley M; Hines L; Vaffis S; Dhatt H; Anderson E; Le D; Black H; Campbell PJ; Kolobova I; Nelson M; Axon DR; Warholak T
J Manag Care Spec Pharm; 2023 Jun; 29(6):680-684. PubMed ID: 37276042
[TBL] [Abstract][Full Text] [Related]
28. Patterns of care and health care resource use among Medicaid-enrolled women with recurrent or metastatic cervical cancer.
Leath CA; Nysenbaum J; Ting J; Zhang YJ; Fiori A; Pauly N
J Manag Care Spec Pharm; 2023 May; 29(5):490-498. PubMed ID: 37121257
[No Abstract] [Full Text] [Related]
29. The economic burden of Parkinson disease among Medicare beneficiaries.
Albarmawi H; Zhou S; Shulman LM; Gandhi AB; Johnson A; Myers DE; Gray D; Alvir J; Onukwugha E
J Manag Care Spec Pharm; 2022 Apr; 28(4):405-414. PubMed ID: 35332791
[No Abstract] [Full Text] [Related]
30. Direct health care costs associated with COVID-19 in the United States.
DeMartino JK; Swallow E; Goldschmidt D; Yang K; Viola M; Radtke T; Kirson N
J Manag Care Spec Pharm; 2022 Sep; 28(9):936-947. PubMed ID: 35722829
[No Abstract] [Full Text] [Related]
31. Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions.
Zhdanava M; Kuvadia H; Joshi K; Daly E; Pilon D; Rossi C; Morrison L; Lefebvre P; Nelson C
J Manag Care Spec Pharm; 2020 Aug; 26(8):996-1007. PubMed ID: 32552362
[TBL] [Abstract][Full Text] [Related]
32. Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database.
Pandya BJ; Chen CC; Medeiros BC; McGuiness CB; Wilson SD; Walsh EH; Wade RL
J Manag Care Spec Pharm; 2020 Jul; 26(7):849-859. PubMed ID: 32281456
[TBL] [Abstract][Full Text] [Related]
33. Time duration and health care resource use during cancer diagnoses in the United States: A large claims database analysis.
Gitlin M; McGarvey N; Shivaprakash N; Cong Z
J Manag Care Spec Pharm; 2023 Jun; 29(6):659-670. PubMed ID: 37276034
[No Abstract] [Full Text] [Related]
34. Health care resource utilization and costs of recurrent
Nelson WW; Scott TA; Boules M; Teigland C; Parente A; Unni S; Feuerstadt P
J Manag Care Spec Pharm; 2021 Jul; 27(7):828-838. PubMed ID: 33703939
[No Abstract] [Full Text] [Related]
35. Economic burden of invasive
Hernandez-Pastor L; Geurtsen J; Baugh B; El Khoury AC; Kalu N; Krishnarajah G; Gauthier-Loiselle M; Bungay R; Cloutier M; Saade E
J Manag Care Spec Pharm; 2023 Aug; 29(8):873-883. PubMed ID: 37523312
[No Abstract] [Full Text] [Related]
36. Health care resource utilization and costs among individuals with vs without Huntington disease in a US population.
To TM; Exuzides A; Abbass IM; Patel AM; Ta JT; Surinach A; Fuller RLM; Luo J
J Manag Care Spec Pharm; 2022 Nov; 28(11):1228-1239. PubMed ID: 36282937
[No Abstract] [Full Text] [Related]
37. Assessment of racial and ethnic inequities in copay card utilization and enrollment in copay adjustment programs.
Ingham M; Sadik K; Zhao X; Song J; Fendrick AM
J Manag Care Spec Pharm; 2023 Sep; 29(9):1084-1092. PubMed ID: 37548953
[No Abstract] [Full Text] [Related]
38. Health care resource utilization and costs in patients receiving long-acting injectable vs oral antipsychotics: A comparative analysis from the Disease Recovery Evaluation and Modification (DREaM) study.
Basu A; Benson C; Turkoz I; Patel C; Baker P; Brown B
J Manag Care Spec Pharm; 2022 Oct; 28(10):1086-1095. PubMed ID: 36125055
[No Abstract] [Full Text] [Related]
39. Disease-free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results-Medicare datac.
Haas NB; Song Y; Willemann Rogerio J; Zhang S; Carley C; Zhu J; Bhattacharya R; Signorovitch J; Sundaram M
Int J Urol; 2023 Mar; 30(3):272-279. PubMed ID: 36788716
[TBL] [Abstract][Full Text] [Related]
40. Within-trial economic analysis of resource use from COMET-ICE: A phase 3 clinical trial evaluating sotrovimab for the treatment of patients with COVID-19 at high risk of progression.
Lokhandwala T; Acharya M; Farrelly E; Coutinho AD; Bell CF; Svedsater H
J Manag Care Spec Pharm; 2022 Nov; 28(11):1261-1271. PubMed ID: 36282931
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
